CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: bryostatin 1
Accession: CHEBI:88353
browse the term
Definition: A member of the class of bryostatins that is (17E)-2-oxooxacyclohexacos-17-ene which is substituted by hydroxy groups at positions 4, 10, and 20; an acetoxy group at position 8; methyl groups at positions 9, 9, 18, and 19; 2-methoxy-2-oxoethylidene groups at positions 14 and 24; an (E,E)-octa-2,4-dienoyloxy group at position 21; and with oxygen bridges linking positions 6 to 10, 12 to 16, and 20 to 24. It is one of the most abundant member of the class of bryostatins.
Synonyms: exact_synonym: (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(acetyloxy)-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.1(3,7).1(11,15)]nonacos-8-en-12-yl (2E,4E)-octa-2,4-dienoate
related_synonym: Formula=C47H68O17; InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5)47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16+,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1; InChIKey=MJQUEDHRCUIRLF-TVIXENOKSA-N; SMILES=C/1(\\C[C@H]2O[C@@H](C1)C[C@]3(C([C@H](C[C@@H](C[C@H](CC(O[C@@H]([C@@H](C)O)C[C@@]4(C\\C(\\[C@@H]([C@](C(C=C2)(C)C)(O4)O)OC(/C=C/C=C/CCC)=O)=C/C(OC)=O)[H])=O)O)O3)OC(C)=O)(C)C)O)=C\\C(OC)=O
xref: CAS:83314-01-6; DrugBank:DB11752; KEGG:C05149; KNApSAcK:C00038654
xref_mesh: MESH:C046785
xref: PMID:10502742; PMID:14735696; PMID:16834754; PMID:20354984; PMID:21175177; PMID:22539107; PMID:22579485; PMID:22986161; PMID:23146662; PMID:23369356; PMID:24291721; PMID:24659806; PMID:24674872; PMID:24677503; PMID:25299527; PMID:25301233; PMID:25472878; PMID:25523423; PMID:25808573; PMID:26225566; PMID:26563568; PMID:26891037; PMID:27068183; PMID:27128726; PMID:27472877; PMID:27941949; PMID:27994072; PMID:28467486; PMID:28472666; PMID:28482641; PMID:28539614; PMID:28590053; PMID:28934369; PMID:29026042; PMID:29066536; PMID:29115558; PMID:8477194; PMID:9195893; PMID:9225066; Reaxys:4349157; Wikipedia:Bryostatin
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
bryostatin 1 results in increased expression of BIRC3 mRNA
CTD
PMID:14527959
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Cd22
CD22 molecule
increases expression
ISO
bryostatin 1 results in increased expression of CD22 protein
CTD
PMID:10741703
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
G
Cdk1
cyclin-dependent kinase 1
multiple interactions
ISO
bryostatin 1 inhibits the reaction [Paclitaxel results in increased activity of CDK1 protein]
CTD
PMID:10516758
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
F3
coagulation factor III, tissue factor
increases expression
ISO
bryostatin 1 results in increased expression of F3 protein
CTD
PMID:25569083
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Il10
interleukin 10
decreases expression
ISO
bryostatin 1 analog results in decreased expression of IL10 mRNA; bryostatin 1 results in decreased expression of IL10 mRNA
CTD
PMID:15614042
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
decreases expression increases expression
ISO
bryostatin 1 analog results in decreased expression of IL12B mRNA bryostatin 1 results in increased expression of IL12B mRNA
CTD
PMID:15614042
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Itgax
integrin subunit alpha X
increases expression
ISO
bryostatin 1 results in increased expression of ITGAX protein
CTD
PMID:10741703
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Prkca
protein kinase C, alpha
multiple interactions decreases expression
ISO
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCA protein bryostatin 1 results in decreased expression of PRKCA protein
CTD
PMID:8892972
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkcb
protein kinase C, beta
multiple interactions decreases expression
ISO
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein; [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein alternative form bryostatin 1 results in decreased expression of PRKCB protein; bryostatin 1 results in decreased expression of PRKCB protein alternative form
CTD
PMID:8892972
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkcg
protein kinase C, gamma
multiple interactions decreases expression
ISO
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCG protein bryostatin 1 results in decreased expression of PRKCG protein
CTD
PMID:8892972
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all